← Search

Data · dataset · 2026

Characterisation, bioactivity assessment and rational design of naturally- occurring peptides from frog skin secretion

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32639493.v1

The brevinin-1 peptides, a well-characterised antimicrobial peptide (AMP) family, were previously demonstrated to have good antimicrobial activity and a high haemolytic capacity.

Description

In chapter three, a naturally - occurring peptide, brevinin-1pl, was isolated from the Northern leopard frog, Rana pipiens through the “shotgun” cloning technique. Chemically synthesised Brevinin-1pl and its four analogues were studied using a series of bioactivity assessment assays.

Brevinin-1pl exhibited a broad spectrum of antimicrobial activity, especially against Gram-positive bacteria, S. aureus, and MRSA with the MIC of only 2 µM. It also shown a significant antibiofilm inhibitory activity against these two strains, with MBIC of 2 µM. Besides, it also showed good anti-proliferative activity against two types of cancer cell lines, H838 and MCF-7. Among the analogues, Brevinin-1pl-6K was found to have a better antimicrobial activity against Gram-negative bacteria, E. coli comparing with the parent peptide.In chapter four, five modified peptides were synthesised via rational design.

Read the rest (2 more)

Among these analogues, brevinin-1pl-del16 displayed an increased bactericidal activity against E. coli , also with a relatively mild haemolysis than the natural peptide. However, its antimicrobial activity was noticed to decreased with the presence of the metal ions. Meanwhile, mechanistic experiments showed that brevinin-1pl and brevinin-1pl-del16, can neutralise LPS and affect the inner and outer membrane permeability of E. coli strains.In chapter five, the peptide ranatensin-R was screened for its antimicrobial and anticancer activities and subjected to haemolytic and cytotoxicity assays.

Meanwhile, 10 analogues were designed based on the parent peptide to increase its antimicrobial potential. After modification, the analogue ranatensin-2277 achieved a MIC of 4 μM for S. aureus, MRSA , and E. coli, whilst the parent peptide shown a much lower bacterial killing ability.<br><br><i>Thesis embargoed until 31 July 2029.</i>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75%
Provenance · 3 source records, 9 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3263949312 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3263949312 d agoJSON v1
DMU Figshareoai:figshare.com:article/3263949312 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title